Vendor Intelligence Report: SRY Labs
Published 12 Nov 2026. 38-page investigative report on who is behind SRY Labs: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.
Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.
Executive summary
SRY Labs is a product-specific vendor, not a single yes/no call. Across 136 Finnrick customer-sample tests, the overall pass rate is 66% (90 pass / 46 fail). The record is materially stronger on the GLP-1 side: tirzepatide and retatrutide are the relative bright spots, while tesamorelin and TB-500 carry clearer avoidance signals, and stricter grading narrows the defensible part of the catalog further.
The counterparty file is heavier than the storefront suggests. The report maps SRY from a live French-facing peptide store into a multi-domain mirror cluster, then back through historical Shanghai Senria records, forum claims about related stores, and a Chinese registry entity that appears real but does not resolve the live storefront’s seller or UBO. The legal notice names no company, registration number, address, publisher or host.
The most serious documentary issue is a pending U.S. federal criminal case tied to the Shanghai Senria trail, with no public plea, trial, sentencing or dismissal found in the reviewed docket. Separately, the payment path observed during checkout was crypto-only, while hidden checkout strings referenced PayGate via Malum and a no-KYC, zero-chargeback gateway; that is a buyer-recourse issue even before product quality is considered.
SRY also shows an old COA trail rather than current lot-level transparency: the located Janoshik/Pastebin/Peptigrity evidence is historical and shop-submitted, while live product pages lacked batch COAs. The full report is built for buyers deciding what, if anything, to buy from SRY, and what proof to demand before using a received lot.
Inside the full report:
- Per-product pass/fail rates, rating trajectories and methodology-divergence charts for all 12 tested products
- Domain-registration, DNS, SPF and origin-server analysis for the SRYLAB mirror cluster
- Chinese corporate registry and ownership layers for Shanghai Senria versus the unresolved storefront operator
- Federal docket, DOJ press release and sanctions-screening context for the Shanghai Senria-linked case
- Checkout evidence covering crypto-only payment, PayGate/Malum code and no-KYC gateway claims
- COA timeline comparing the 2025 Pastebin/Peptigrity trail, live product pages and the Trustpilot dispute
Risk assessment
- Criminal/legal exposure risk — high: Shanghai Senria-linked entity remains under pending M.D. Fla. indictment for attempted protonitazene importation and attempted international money laundering; no public plea, sentencing or dismissal appears.
- Product-specific quality risk — tesamorelin, CJC-1295, TB-500, BPC-157, cagrilintide, sermorelin, PT-141 — high: Finnrick records weak results for these SRY products: tesamorelin 35.14%, CJC-1295 33.47%, TB-500 39.07%, BPC-157 48.11%, cagrilintide 49.2%, sermorelin 41.41% and PT-141 59.08%.
- Payment and buyer-recourse risk — high: Visible checkout was crypto-only; hidden card route referenced PayGate via Malum / withoutkyc.to, advertised as no-KYC, zero-KYB and zero-chargeback.
- Corporate identity and UBO opacity risk — high: Legal notice names no company, registration number, address, publisher or host; Shanghai Senria registry trail does not prove the current storefront operator or UBO.
- Claims and COA-transparency risk — medium: Current site claims “99.9% purity on tested lots” but product pages showed no current lot COAs; located Pastebin/Peptigrity COA trail is shop-submitted and dated September 2025.
- Brand-confusion and domain-rotation risk — medium: Multiple live and dormant SRY domains, a recorded -shop mirror, no official reseller list and no anti-counterfeit process leave buyers exposed to wrong-channel purchases.
- SEO reputation-manipulation risk — medium: Keyword-stuffed pages on unrelated institutional domains, including pages conflating SRY with unrelated suppliers, degrade search-result reliability; operator unknown.